Home›Stock Screener›Poly Medicure

Poly Medicure Share Price Today | Stock Price & Poly Medicure Share Screener

POLYMED Healthcare Equipment & Supplies
Live Share Price NSE
₹1654.50
▲ 4.90 (0.30%)
2026-11-18 00:00:00
Live Share Price BSE
₹1652.85
▲ 4.90 (0.30%)
2026-11-18 00:00:00

As of November 18, 2026, the live Poly Medicure share price (NSE: POLYMED) is ₹1,654.50 on NSE and ₹1,652.85 on BSE, up 0.30% from the previous close, with shares trading between ₹1,640.10 and ₹1,686.20 in today's trading session, and a 52-week range of ₹1,191.10–₹1,967.40. Track Poly Medicure market cap to gauge the company's total market size. Use the Poly Medicure stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Poly Medicure opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹554 and net income of ₹65, with EBITDA of ₹130, an operating margin of 21.0% and a profit margin of 11.7%.

Poly Medicure Market Cap ₹17,072.31 Cr.
POLYMED P/E Ratio (TTM) 53.80
Poly Medicure P/B Ratio 5.21
EPS (TTM) ₹31.79
Dividend Yield 0.21%
Debt to Equity 0.09
POLYMED 52 Week High ₹1967.40
Poly Medicure 52 Week Low ₹1191.10
Operating Margin 21.00%
Profit Margin 11.73%
POLYMED Revenue (TTM) ₹554.00
EBITDA ₹130.00
Net Income ₹65.00
Total Assets ₹3,919.00
Total Equity ₹3,149.00

Poly Medicure Share Price Chart

Track the current stock price of Poly Medicure with an interactive chart. Analyse POLYMED share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Poly Medicure stock quote in one place.

The quote of ₹1,654.50 sits between the 52-week low of ₹1,191.10 and the 52-week high of ₹1,967.40, and the latest session moved 0.30% from the previous close.

Poly Medicure Company Profile - Fundamental Screener

Screen Poly Medicure company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for POLYMED shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Equipment & Supplies industry, with Devendra Raj Mehta listed as chairperson or CEO, and it trades under ISIN INE205C01021.

Business Overview

Poly Medicure Limited is an Indian medical device manufacturer founded in 1995. The company produces over 130 SKUs of medical devices across various product verticals including infusion therapy, oncology, anesthesia, respiratory care, urology, gastroenterology, blood management, surgery, and dialysis. Poly Medicure operates ten manufacturing facilities across India, China, Egypt, and...more

Company Details

Classification

Sector Healthcare
Industry Healthcare Equipment & Supplies
Sub-Sector Healthcare Equipment & Supplies
Segment E

Identifiers and Leadership

Chairperson/CEO Devendra Raj Mehta
ISIN INE205C01021

Poly Medicure Balance Sheet Screener

Screen POLYMED balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹3,919, up from ₹3,193 in 2025.

Latest statistics put total assets at ₹3,919 and shareholder funds at ₹3,149, with a leverage ratio of 0.09.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 3,919 3,193 1,859 1,577 1,377 1,224 767 654 565 457
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 1,694 1,084 867 635 488 426 363 306 265 207

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 194 57 37 42 63 87 135 119 104 72
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 3,149 2,766 1,470 1,242 1,088 966 435 381 338 272
Share Capital 51 51 48 48 48 48 44 44 44 44
Reserves & Surplus 3,056 2,715 1,422 1,194 1,040 918 391 337 294 227

Poly Medicure Income Statement Screener - Profit & Revenue Analysis

Screen Poly Medicure income statement and profit fundamentals. Analyze POLYMED quarterly results. Poly Medicure reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹554 and net profit was ₹65, equal to earnings per unit of ₹6.54, at an operating margin of 21%.

In that period expenses were ₹424, interest cost ₹6 and tax ₹20. The next period listed, 2026-Jun, shows revenue of ₹560 and net profit of ₹85.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec

Revenue and Expenses

Revenue 554 560 611 467 447 479 522 393 402 447 448 316 335 352 357
Expenses 424 400 443 321 298 329 389 282 281 305 310 224 234 253 249

Operating Costs and Margins

EBITDA 130 160 168 146 149 150 132 112 121 142 138 92 101 99 108
Operating Profit % 21.00% 24.00% 24.00% 27.00% 26.00% 26.00% 21.00% 26.00% 27.00% 27.00% 27.00% 27.00% 27.00% 25.00% 27.00%
Depreciation 38 36 35 21 23 25 29 16 20 21 21 15 16 16 16
Interest 6 7 7 2 3 3 6 3 3 3 3 2 3 2 4

Profit and Earnings

Profit Before Tax 85 117 126 123 123 122 98 93 99 118 113 75 83 81 88
Tax 20 32 30 31 30 30 27 24 24 31 28 16 20 19 23
Net Profit 65 85 95 92 93 92 71 68 74 87 85 59 63 62 65
EPS 6.54 8.49 9.38 8.92 9.19 9.06 7.00 7.12 7.71 9.01 8.48 6.13 6.54 6.48 6.78

Poly Medicure Cash Flow Screener - Liquidity Fundamentals

Screen POLYMED cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹246, and net cash flow was an inflow of ₹43.

Over the same period, investing activities used ₹224 and financing activities provided ₹20.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 246 233 266 191 124 119 131 107 75 56
Investing Activities -224 -1,187 -241 -179 -85 -436 -110 -101 -88 -56

Financing and Net Cash

Financing Activities 20 951 -20 -13 -35 317 -21 -5 16 0
Net Cash Flow 43 -3 5 -1 3 0 1 1 3 0

Poly Medicure Shareholding Pattern Screener

See Poly Medicure shareholding pattern with promoter, FII, and DII holdings. Check Poly Medicure promoter holding and ownership changes for POLYMED on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 62.42%, foreign institutions 5.91%, domestic institutions 15.59% and the public 12.61%, spread across 73,414 shareholders.

The shareholder count was 73,414 in 2026-Mar, compared with 73,643 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 62.42% 62.42% 62.42% 62.44% 62.44% 62.42% 62.42% 53.15%

Institutional Investors

FII Holding 5.91% 5.57% 5.35% 11.46% 11.41% 9.77% 9.40% 12.38%
DII Holding 15.59% 16.08% 15.90% 11.96% 11.72% 13.54% 13.84% 7.22%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 12.61% 12.18% 12.31% 11.08% 11.37% 11.25% 11.30% 11.34%
Other Holding 3.47% 3.76% 4.02% 3.07% 3.07% 3.02% 3.04% 15.92%
Shareholder Count 73,414 73,643 74,153 65,583 71,142 64,400 67,750 36,712

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Poly Medicure. Poly Medicure dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹3.50 per unit for 2026-March, a yield of 0.21%, compared with ₹3.50 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹3.50, ₹3.50 and ₹3.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹3.50 0.21%
2025-March ₹3.50 0.29%
2024-March ₹3.00 0.13%
2023-March ₹3.00 0.19%
2022-March ₹2.50 0.27%
2021-March ₹2.50 0.26%
2020-March ₹2.00 0.24%
2019-March ₹2.00 0.86%
2018-March ₹2.00 0.91%
2017-March ₹2.50 1.00%

Poly Medicure Stock Index Membership - Nifty & Sensex

See which indices include Poly Medicure stock. Check POLYMED index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 19 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX MSL400.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY 500
NIFTY MIDSMALLCAP400 MOMENTUM QUALITY 100
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY SMALLCAP250 MOMENTUM QUALITY 100
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MOMENTUM 50
NIFTY500 MULTICAP
NIFTY500 MULTICAP MOMENTUM QUALITY 50
NIFTY500 SHARIAH

Poly Medicure Market Events Screener - Corporate Actions

Get Poly Medicure corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Poly Medicure stock events that may affect POLYMED share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 5, 2026, with a record date of November 5, 2026.

It is followed by Annual General Meeting dated September 5, 2026 and Dividend dated August 28, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-05 2026-11-05 Quarterly Result Announcement NA 7.56%
2026-09-05 2026-09-05 Annual General Meeting NA -6.19%
2026-08-28 2026-08-29 Dividend ₹ 3.50 /share 8.43%
2026-08-07 2026-08-07 Quarterly Result Announcement NA 2.33%
2026-05-25 2026-05-25 Quarterly Result Announcement NA -0.03%
2026-02-05 2026-02-05 Quarterly Result Announcement NA 0.14%
2025-11-08 2025-11-08 Quarterly Result Announcement NA -4.08%
2025-09-25 2025-09-25 Annual General Meeting NA -4.14%
2025-09-18 2025-09-18 Dividend ₹ 3.50 /share -22.75%
2025-08-08 2025-08-08 Quarterly Result Announcement NA -6.11%
2025-05-06 2025-05-06 Quarterly Result Announcement NA -0.13%
2025-02-03 2025-02-03 Quarterly Result Announcement NA -0.46%
2024-10-28 2024-10-28 Quarterly Result Announcement NA 2.58%
2024-09-26 2024-09-26 Annual General Meeting NA -7.22%
2024-09-19 2024-09-20 Dividend ₹ 3.00 /share 48.83%

Poly Medicure Competitors Screener - Peer Stocks Comparison

Screen POLYMED competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Molbio Diagnostics 17,129 121.60 1,455 41.57% 164 60.75
Poly Medicure 17,072 53.80 1,995 13.43% 321 64.63
Sahajanand Medical Technologies 5,522 78.70 1,219 17.64% 69 75.49
Tarsons Products 1,651 226.00 447 9.38% 14 47.58
Laxmi Dental 1,099 34.60 286 18.15% 26 57.90
Q-Line Biotech 1,026 20.40 347 7.89% 56 30.31
Hemant Surgical Industries 936 51.00 238 112.99% 18 63.65
Vasa Denticity 846 69.90 283 12.77% 10 65.05
Osel Devices 656 23.40 295 57.88% 29 50.35
Fabtech Technologies 609 17.50 431 28.40% 38 53.39

Poly Medicure Company Announcements - News & Reports Screener

Screen POLYMED latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 15, 2026.

The next most recent announcements are dated November 13, 2026 and November 9, 2026.

Date Update Actions
2026-11-15 Intimation For The Schedule Of Investors/Analysts Call/Meet. -
2026-11-13 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-11-09 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -
2026-11-08 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-08 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-11-05 Intimation Of Revision Of Policies And/Or Code Of Conduct Of The Company -
2026-11-05 Statement Of Deviation(S) Or Variation(S) If Any Of Utilization Of Proceeds Received From Qualified Institutions Placement (QIP). -
2026-11-05 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-05 Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2026 -
2026-11-05 Board Meeting Outcome for Outcome Of The Board Meeting -
2026-10-31 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-29 Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On 05Th November 2026 -
2026-10-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-28 Closure of Trading Window -
2026-09-24 Intimation For The Schedule Of Investors/Analysts Call/Meet. -
2026-09-23 Intimation For The Schedule Of Investors/Analysts Call/Meet. -
2026-09-21 Intimation For The Schedule Of Investors/Analysts Call/Meet. -
2026-09-18 Intimation For The Schedule Of Investors/Analysts Call/Meet. -
2026-09-07 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-05 Shareholder Meeting / Postal Ballot-Outcome of AGM -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹1,654.50, within a 52-week range of ₹1,191.10 to ₹1,967.40. The P/E ratio is 53.80 and the P/B ratio is 5.21, with earnings per unit of ₹31.79. Market capitalisation stands at ₹17,072.31 Cr and the dividend yield is 0.21%. The company operates in the Healthcare sector, in the Healthcare Equipment & Supplies industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 18, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.